Drug Maker Teva to Pay Over $500 Million in New York Drug Case Settlement
The last remaining defendants in New York’s once-sprawling opioid trial settled on Thursday.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.